Imperial Brands lifts adjusted profit for sixth year as pricing offsets falling volumes

Imperial Brands delivered a sixth straight year of growth in adjusted profit, with cigarette price rises more than offsetting falling volumes.

One-off costs pushed reported profit sharply lower, but the underlying picture was no less robust.

- Advertisement -

Adjusted operating profit rose 3.7% at constant currency to £4.13bn for the year to 30 September 2026, while tobacco and next generation products (NGP) net revenue grew 2.1% to £8.5bn.

On a reported basis, operating profit fell 10.2% to £3.13bn, weighed down by charges relating to the Delaware settlement and restructuring costs under the group’s 2030 strategy.

Adjusted earnings per share climbed 8.8% to 341.0p, helped by the reducing share count from the buyback programme. Reported EPS fell 3.3% to 242.9p.

Pricing does the heavy lifting

Despite falling volumes, combustibles remain the business’s core. Tobacco net revenue rose 1.7% as pricing of 5.1% offset a 3.4% fall in volumes to 180.6bn stick equivalents.

- Advertisement -

Much of the volume decline came from Europe, where Imperial deliberately cut German private label production ahead of closing its Langenhagen factory.

The Americas was the standout region, with tobacco net revenue up 3.3% on robust pricing and improving US market volumes. Europe slipped 0.5%, though it grew 0.4% excluding private label, helped by good execution in Germany and the UK. In Africa, Asia, Australasia and Central & Eastern Europe, net revenue rose 2.9%, or 7.6% excluding a weak Australia.

Aggregate cigarette market share across its five priority markets slipped 15 basis points.

NGP growing but still loss-making

Net revenue from next generation products rose 11.4%, with market share gains in vapes, heated tobacco and modern oral nicotine. Strong growth in Europe more than offset a decline in the US, where the company withdrew its legacy myblu vape.

Zone nicotine pouches continued to grow in the US, while the acquisitions of Black Buffalo in the US and Helwit in Sweden added to the oral portfolio.

Despite rapid growth, the division is still not profitable, posting an adjusted operating loss of £63m, a £5m improvement on last year.

From FY27, Imperial will fold its traditional Nordic snus business into NGP under a new ‘Smokeless’ category, which on FY26 numbers would have generated £554m of net revenue and a £14m adjusted operating profit.

Cash and returns

Free cash flow came in at £2.6bn. The dividend rises 4% to 166.72p, the FY26 £1.45bn buyback has been completed and a £1.5bn programme is under way for FY27. Adjusted net debt edged up to £8.8bn, with leverage steady at 2.0 times EBITDA.

These are the types of numbers investors who hold Imperial for its income attributes would want to see.

The transformation programme has delivered £90m of annualised savings so far, and the company reiterated its target of at least £320m a year by 2030. It completed programmes in FY26 that will cut 2,100 roles and expects a further 2,100 to 2,500 to go by the end of 2030.

“We continue to perform and transform,” said chief executive Lukas Paravicini. “Our expectations for the coming year are in line with our medium-term guidance.”

Imperial Brands outlook

Imperial expects adjusted operating profit to grow at a similar rate in FY27, with low-single-digit tobacco and double-digit NGP net revenue growth, and at least high-single-digit growth in adjusted EPS.

Imperial Brands shares were almost flat at the time of writing.

Latest News

More Articles Like This